Melissa Uppal

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: India

Consulting Services

Research Consulting Legal Support

Areas Of Interest

MEN IIb Zhong Yi Xue Deers Volkmann Canals Acyl CoA Retinol Acyltransferase Ectodysplasin 1, Anhidrotic Receptor Common Variable Hypogammaglobulinemias Electric Anesthesias Food Sciences Synthetic Postcoital Contraceptives Nursing Diagnoses Boards, Specialty Cynanchum Air Force Hospitals Deficiencies, Factor XII Activators, Cannabinoid Receptor Corpses Native-Born Recombinant 1-165 Erythropoietin, Glycoform Alpha Synthetase, Uroporphyrinogen III

Professional Narrative

Dr. Melissa Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Amgen 2008
Director Medicine, Mayo Clinic 1992

Education

Bachelor of science in nursing, Yale School of Medicine 2017
Master of Science in physician assistant, Baylor College 1997

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :